Astrana Health, Inc.
ASTH
$37.85
$0.471.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 43.77M | 30.39M | 25.65M | 13.18M | 12.21M |
| Total Other Revenue | 3.48B | 3.15B | 2.87B | 2.41B | 2.24B |
| Total Revenue | 3.53B | 3.18B | 2.90B | 2.42B | 2.25B |
| Cost of Revenue | 3.15B | 2.84B | 2.60B | 2.15B | 1.98B |
| Gross Profit | 375.95M | 341.53M | 296.97M | 273.27M | 268.76M |
| SG&A Expenses | 225.60M | 206.35M | 186.94M | 172.65M | 157.88M |
| Depreciation & Amortization | 54.38M | 45.75M | 37.47M | 29.14M | 29.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.43B | 3.09B | 2.82B | 2.35B | 2.17B |
| Operating Income | 95.97M | 89.44M | 72.56M | 71.48M | 81.20M |
| Income Before Tax | 49.71M | 39.61M | 30.21M | 51.35M | 66.42M |
| Income Tax Expenses | 18.73M | 15.53M | 20.47M | 23.71M | 27.13M |
| Earnings from Continuing Operations | 30.99 | 24.08 | 9.74 | 27.64 | 39.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -755.00K | -1.59M | -200.00K | -2.38M | -4.29M |
| Net Income | 30.23M | 22.49M | 9.54M | 25.26M | 35.01M |
| EBIT | 95.97M | 89.44M | 72.56M | 71.48M | 81.20M |
| EBITDA | 150.35M | 135.18M | 110.03M | 100.62M | 110.88M |
| EPS Basic | 0.62 | 0.46 | 0.19 | 0.52 | 0.73 |
| Normalized Basic EPS | 0.68 | 0.57 | 0.54 | 0.64 | 0.80 |
| EPS Diluted | 0.61 | 0.46 | 0.19 | 0.51 | 0.72 |
| Normalized Diluted EPS | 0.67 | 0.56 | 0.53 | 0.63 | 0.79 |
| Average Basic Shares Outstanding | 195.76M | 196.11M | 193.22M | 191.69M | 190.11M |
| Average Diluted Shares Outstanding | 198.25M | 197.32M | 194.13M | 192.89M | 191.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 10.33% | 37.68% | 65.36% | 24.68% | 15.58% |